M5 MEQs /10/2016 Case 3: Ms Hui Bo Gao

Size: px
Start display at page:

Download "M5 MEQs /10/2016 Case 3: Ms Hui Bo Gao"

Transcription

1 M5 MEQs /10/2016 Case 3: Ms Hui Bo Gao

2 Welcome to the amazing world of hematology J

3 Question 1.1: Ms Hui Bo Gao Ms Hui is a 30 years old female. She has no past medical history. She was referred from her GP with the presentation of 4 days history of fever and a rash. She has no other bleeding manifestations. On examination, her vitals was T38.5 BP 100/62, HR 80 RR22 SpO2 99% on RA. She looks comfortable. Examination was revealing of a rash over the limbs and trunk which is non-blanchable.

4

5 1.1 Question: Ms Hui Bo Gao Q1. Which are the 2 most important test will you order first? Full blood count Liver Panel Renal Panel HIV Test Dengue Serology PT/APTT Blood Cultures

6 A classic image of purpura

7 1.1 Question: Ms Hui Bo Gao Q1. Which are the 2 most important test will you order first? Full blood count looking for thrombocytopenia Liver Panel Renal Panel HIV Test Dengue Serology dengue rash usually appears when the fever lyses; this pt is still febrile with a rash PT/APTT looking for coagulopathy Blood Cultures The rest are not wrong but you are being asked to prioritise!

8 Small lesions (<0.5cm) Macule flat, cirumscribed, colored, non palpable Papule raised, solid and palpable Vesicle raised, palpable, clear fluid-filled Pustule raised, palpable, pus filled (leukocytes or keratin) Large lesions (>0.5cm) Patch large macule (flat non-palpable colored area) Plaque superficially raised, circumscribed solid area Nodule distinct large papule Bulla - large vesicle (blisters if epidermal layer completely sloughed off) Wheal firm and edematous plaque (edema of the dermis) Other Plaque/scaley papule Eschar Erosion/ulcer Purpura/petechia Plaque/smooth papule

9 Purpura is used to describe red purple lesions that result from the extravasation of blood into the skin or mucous membranes Non-blanchable Purpura may be palpable or non-palpable (flat/macular) Macular purpura is divided on 2 morphologies characterized by size and typically non-inflammatory Petechiae < 3mm Ecchymosis - > 5mm Palpable purpura: usually a sign of vascular inflammation

10 Question 1.2: Ms Hui Bo Gao ED bloods shows the following: Hb 6.9 TW 50.2 Plt 30 N.myelocytes Present Promyelocytes 90% Renal panel: U 7 Na 131 K 3.5 Bicarb 20 Cr 60 Liver Panel TBil 4 ALP 120 AST 55 ALT 42 PT 42 APTT 82 You review the patient in the ward, vitals T 38.9 BP 94/70 HR 80. She is still comfortable and does not have any bleeding manifestations.

11 Question 1.2: Ms Hui Bo Gao ED bloods shows the following: Hb 6.9 TW 50.2 Plt 30 N.myelocytes Present Promyelocytes 90% Renal panel: U 7 Na 131 K 3.5 Bicarb 20 Cr 60 Liver Panel TBil 4 ALP 120 AST 55 ALT 42 PT 42 APTT 82 You review the patient in the ward, vitals T 38.9 BP 94/70 HR 80. She is still comfortable and does not have any bleeding manifestations. TW 20, may be infection. TW 100, think leukaemia

12 Question 1.2: Ms Hui Bo Gao Q2. As the on-call HO, which of the following therapies would you initiate? (Choose 3 of 10) * Transfuse 1 pint PCT Transfuse platelets Referral to the haematologyon call Transfer to Medical ICA for monitoring Arrange for aphresis Start IV fluids 2L NS over 24H Start hydroxyurea1g TDS Repeat the FBC Do blood cultures and start empirical antibiotics Start dexamethasone

13 Don t know what is going on. Always go back to basics Transfuse 1 pint PCT Transfuse platelets Referral to the haematologyon call Transfer to Medical ICA for monitoring Arrange for aphresis --- you wouldn t start this yourself. Call haem! Start IV fluids 2L NS over 24H Start hydroxyurea1g TDS --- you wouldn t start this yourself. Call haem! Repeat the FBC Do blood cultures and start empirical antibiotics Start dexamethasone --- big no-no in acute leukaemia cases! Can cause tumor lysis.

14 Now contextualized Transfuse 1 pint PCT Transfuse platelets Referral to the haematologyon call Transfer to Medical ICA for monitoring --- patient is still well Arrange for aphresis Start IV fluids 2L NS over 24H Start hydroxyurea1g TDS Repeat the FBC --- you don t believe the lab is it? Do blood cultures and start empirical antibiotics Start dexamethasone

15 Some basic management principles Transfuse 1 pint PCT Transfuse platelets Referral to the haematologyon call Transfer to Medical ICA for monitoring Arrange for aphresis Start IV fluids 2L NS over 24H --- hydration is rarely wrong Start hydroxyurea1g TDS Repeat the FBC Do blood cultures and start empirical antibiotics --- probably quite safe Start dexamethasone

16 Question 1.3: Ms Hui Bo Gao You also noticed that the APTT/PT is prolonged. Your MO tells you to order other investigations to work up the cause. Q3. What investigation will you order next for this patient (Choose 2) 50% correction studies Direct coombs test D-Dimer Liver function test Fibrinogen Platelet function test Bleeding time

17 Question 1.3: Ms Hui Bo Gao You also noticed that the APTT/PT is prolonged. Your MO tells you to order other investigations to work up the cause. Q3. What investigation will you order next for this patient (Choose 2) 50% correction studies Direct coombs test D-Dimer Liver function test Fibrinogen Platelet function test Bleeding time This question is asking you, what do you think is the cause of prolonged aptt/pt? The investigation you choose is to confirm your suspicion. In this case coagulopathy is due to DIVC (happens in acute leukaemia or v sick pt) not due to liver disease or factor inhibitors or autoimmune dx.

18

19 Investigations in DIC: Prolonged of the prothrombintime (PT) Reflects reduced activity of the components of the extrinsic and common pathways Include factors VII, X, V, and prothrombin, which are the most frequently decreased clotting proteins in DIC Prolonged Activated partial thromboplastin time (aptt) Measures the intrinsic and common pathways of coagulation Is sensitive to deficiencies of factors XII, XI, IX and VIII Less sensitive than the PT to deficiencies of components of the common pathway

20 Investigations in DIC: Thrombocytopenia: Consumptive Plasma fibrinogen: Usually low in acute decompensated DIC Cavet: May be elevated as an acute phase reactant D-Dimer: high - indicative of fibrinolysis Peripheral Blood Film Thrombocytopenia Large platelets Fragmented red cells (schistocytes).

21 Question 1.4: Ms Hui Bo Gao The haematology reviews the blood film to confirm the diagnosis.

22 Question 1.4: Ms Hui Bo Gao Q4. What is the most likely diagnosis? * Acute myeloid leukemia Burkitts Lymphoma Acute promyelocyticleukemia Acute lymphoblastic leukemia Chronic myeloid leukemia

23 Question 1.4: Ms Hui Bo Gao Q4. What is the most likely diagnosis? * Acute myeloid leukemia Burkitts Lymphoma Acute promyelocyticleukemia Acute lymphoblastic leukemia Chronic myeloid leukemia

24 The answer was already in the stem! Promyelocytes: Very granular Weird looking big nuclei Auer rods

25 Question 1.5: Ms Hui Bo Gao The diagnosis of acute promyelocytic leukemia was made. The haematology registrars proceeds to order the appropriate treatment. Q5. What treatment was ordered? (Choose 1) * All trans retinoic acid Dexamethasone 4g TDS Hyper-CVAD IA3+7 Allogenic transplant

26 Question 1.5: Ms Hui Bo Gao The diagnosis of acute promyelocytic leukemia was made. The haematology registrars proceeds to order the appropriate treatment. Q5. What treatment was ordered? (Choose 1) * All trans retinoic acid Dexamethasone 4g TDS Hyper-CVAD IA3+7 Allogenic transplant

27 Management of APML Medical emergency: due to the risk of a life threatening bleed Treatment is started on clinical suspicion ATRA (All trans-retinotic acid) aka vitamin A Supportive management for bleeding complications

28

29 Question 1.6: Ms Hui Bo Gao The next day you were called to see Ms Tan for hemoptysis. The nurses informed you that she had coughed out blood 6 times in the last 1 hour, each time filling up a specimen blood (50ml). On review of the patient, Ms Tan was talking in full sentences. She does not complain of any breathlessness or chest pain. On examination, RR 24 SpO2 97% on RA. Heart sounds are heard with no addition murmurs or heart sounds. Lungs have reduced air entry at the bases, no additional sounds were heard.

30 Question 1.6: Ms Hui Bo Gao Q6. What will you do next in the management of this patient? Put patient on intranasal oxygen Consider elective intubation Patient is clinically stable, ask the nurse to inform you if further episodes occur Arrange for respiratory review and bronchoscopy Urgent thorax imaging with a CT thorax

31 Question 1.6: Ms Hui Bo Gao Q6. What will you do next in the management of this patient? Put patient on intranasal oxygen Consider elective intubation Patient is clinically stable, ask the nurse to inform you if further episodes occur Arrange for respiratory review and bronchoscopy Urgent thorax imaging with a CT thorax

32 Massive hemoptysis No clear definition: 500ml over 24H or 150ml over 1h Think of the anatomical dead space - the volume that is life threatening by virtue of airway obstruction (anatomical dead space is only ml) Medical emergency and should be addressed immediately. Initial priorities are stabilisation of the patient and protection of the non-bleeding lung

33 ABC first maintain airway patency: Asphyxiation is the most frequent complication of massive hemoptysis Assessment: History, Physical Examination, investigations Investigation: FBC/ PT/APTT/ CXR Initial Management: Oxygenation Lateral position ( if site of bleed is known - affected lung in dependent position) IV access Correct contributing coagulopathy/ thrombocytopenia Localize the source of the bleeding: Bronchoscpoy

34 Question 1.7: Ms Hui Bo Gao Patient was electively intubated and transferred to ICU. A bronchoscopy was done which showed diffuse bleeding. She was supported with blood products including platelets, fresh frozen plasma and cryoprecipitate. The bleeding finally stops and the ICU team considers extubation.

35 Question 1.7: Ms Hui Bo Gao Q7. Which of the following regarding blood transfusions is INCORRECT The typical effective dose of FFP is 10 to 15 ml/kg FFP is effective at treating mild coagulopathies characterized by INR of less than 1.85 Cryoprecipitate contains factor VIII, von Willebrand factor, factor XIII, fibronectin, and fibrinogen The risk for bacterial infection and sepsis is increased in patients receiving platelet transfusions compared with other blood products FFP is an acellular product

36 Question 1.7: Ms Hui Bo Gao Q7. Which of the following regarding blood transfusions is INCORRECT The typical effective dose of FFP is 10 to 15 ml/kg FFP is effective at treating mild coagulopathies characterized by INR of less than 1.85 Cryoprecipitate contains factor VIII, von Willebrand factor, factor XIII, fibronectin, and fibrinogen The risk for bacterial infection and sepsis is increased in patients receiving platelet transfusions compared with other blood products FFP is an acellular product

37 What can you transfuse Cellular products: RBC, platelets Plasma products: FFP, Cyroprecipitate, plasma derived products Approach Know your indication for transfusion Weigh the risk and benefits Remember: Blood products is a medication and is a public resource (donated)

38 Red blood cells Indication: improve the oxygen-carrying capacity of blood. Humans display many compensatory responses to maintain oxygen delivery, and no single hemoglobin trigger exists General guidelines: Hb >7 (Adjust base on patient s physiological state) Targets: Typically 250 to 300 ml with an expected increase in the hemoglobin of 1 g/dl (10 g/l) in a nonbleedingadult.

39 Platelets Indication: prophylactic and therapeutic for hemorrhage in patients with thrombocytopenia Options available: pooled or single donor 1 unit from a single donor = approx 4-5 pooled donors Targets: usually unit transfusion should bring up platelet count by at least k Note: Stored at room temperature the warmer storage conditions allow for proliferation of any contaminating bacteria

40 Fresh Frozen Plasma Indication: Prophylactic or therapeutic in patients with major coagulopathy, warfarin reversal, massive transfusion Contains all the blood clotting factors Targets: FFP volume ml; effective dosing 10-15ml/kg Note: Correction with FFP is not a linear phenomenoni Unlike PCT 1 pack PCT increases Hb ~1 g The amount of FFP required to bring INR from 10 to 9 is much less than that required to bring INR from 3 to 2.

41

42 Conclusions Haematology is fun Haematology is not scary!! Haematology is easy!!!

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)

Effective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature) 1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory

More information

ACQUIRED COAGULATION ABNORMALITIES

ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES ACQUIRED COAGULATION ABNORMALITIES - causes 1. Liver disease 2. Vitamin K deficiency 3. Increased consumption of the clotting factors (disseminated intravascular coagulation

More information

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne

John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne John Davidson Consultant in Intensive Care Medicine Freeman Hospital, Newcastle upon Tyne Overview of coagulation Testing coagulation Coagulopathy in ICU Incidence Causes Evaluation Management Coagulation

More information

CrackCast Episode 7 Blood and Blood Components

CrackCast Episode 7 Blood and Blood Components CrackCast Episode 7 Blood and Blood Components Episode Overview: 1) Describe the 3 categories of blood antigens 2) Who is the universal donor and why? 3) Define massive transfusion 4) List 5 physiologic

More information

Coagulation, Haemostasis and interpretation of Coagulation tests

Coagulation, Haemostasis and interpretation of Coagulation tests Coagulation, Haemostasis and interpretation of Coagulation tests Learning Outcomes Indicate the normal ranges for routine clotting screen and explain what each measurement means Recognise how to detect

More information

Transfusion Requirements and Management in Trauma RACHEL JACK

Transfusion Requirements and Management in Trauma RACHEL JACK Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension

More information

Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital

Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital Haematological Emergencies (Part 1) Ray Mun Koo Haematology Advanced Trainee Canberra Hospital Case Number 1 43 year old male presenting with fevers, abdominal distension and weight gain over 2 weeks.

More information

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006

TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.

More information

Blood is serious business

Blood is serious business Transfusion at RCH BLOOD TRANSFUSION Anthea Greenway Dept of Clinical Haematology >10000 fresh blood products per year Supports craniofacial and cardiac surgery Support bone marrow, liver transplant and

More information

BLEEDING DISORDERS Simple complement:

BLEEDING DISORDERS Simple complement: BLEEDING DISORDERS Simple complement: 1. Select the statement that describe the thrombocytopenia definition: A. Marked decrease of the Von Willebrandt factor B. Absence of antihemophilic factor A C. Disorder

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013 General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding

More information

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion? Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching

More information

Transfusion Medicine Best Practices: Indications for Blood Components

Transfusion Medicine Best Practices: Indications for Blood Components Transfusion Medicine Best Practices: 1.0 Policy Statements 1.1 Regional Health Authorities (RHAs) shall develop policies, processes and procedures for ordering, distribution, storage, transfusion and administration

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN The student should be able:» To identify the mechanism of homeostasis and the role of vessels, platelets

More information

HEME 10 Bleeding Disorders

HEME 10 Bleeding Disorders HEME 10 Bleeding Disorders When injury occurs, three mechanisms occur Blood vessels Primary hemostasis Secondary hemostasis Diseases of the blood vessels Platelet disorders Thrombocytopenia Functional

More information

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:

More information

Crossmatching and Issuing Blood Components; Indications and Effects.

Crossmatching and Issuing Blood Components; Indications and Effects. Crossmatching and Issuing Blood Components; Indications and Effects. Alison Muir Blood Transfusion, Blood Sciences, Newcastle Trust Topics Covered Taking the blood sample ABO Group Antibody Screening Compatibility

More information

Blood Component Therapy

Blood Component Therapy Blood Component Therapy Dr Anupam Chhabra Incharge-Transfusion Medicine Pushpanjali Crosslay Hopital NCR-Delhi Introduction Blood a blood components are considered drugs because of their use in treating

More information

TRANSFUSIONS FIRST, DO NO HARM

TRANSFUSIONS FIRST, DO NO HARM TRANSFUSIONS FIRST, DO NO HARM BECAUSE BLOOD CAN KILL 7 TRALI DEATHS SINCE 2002 WMC 5 women BECAUSE In OB you are transfusing 2 instead of 1 BECAUSE BLOOD IS A LIQUID TRANSPLANT RISKS versus BENEFITS versus

More information

Approach to disseminated intravascular coagulation

Approach to disseminated intravascular coagulation Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS

More information

Managing Coagulopathy in Intensive Care Setting

Managing Coagulopathy in Intensive Care Setting Managing Coagulopathy in Intensive Care Setting Dr Rock LEUNG Associate Consultant Division of Haematology, Department of Pathology & Clinical Biochemistry Queen Mary Hospital Normal Haemostasis Primary

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug

More information

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Transfusion 2004: Current Practice Standards Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service Massive Transfusion Protocol (MTP) When should it be activated? Massive bleeding i.e. loss of one blood

More information

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO POSTGRADUATE DIPLOMA IN CLINICAL HAEMATOLOGY EXAMINATION - JUNE 2014 PAPER I - ESSAY

POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO POSTGRADUATE DIPLOMA IN CLINICAL HAEMATOLOGY EXAMINATION - JUNE 2014 PAPER I - ESSAY POSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO POSTGRADUATE DIPLOMA IN CLINICAL HAEMATOLOGY EXAMINATION - JUNE 2014 Date :- 23 rd June 2014 Time 1.00 p.m. - 4.00 p.m. Answer four questions only.

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Bleeding Disorders Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph Normal hemostasis The normal hemostatic response involves interactions among: The blood vessel wall (endothelium)

More information

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate Approach to bleeding disorders &treatment by RAJESH.N General medicine post graduate 2 Approach to a patient of bleeding diathesis 1. Clinical evaluation: History, Clinical features 2. Laboratory approach:

More information

Learning Objectives: At the end of this exercise, the student will be able to:

Learning Objectives: At the end of this exercise, the student will be able to: Applications in Transfusion Medicine- A CBL Exercise- Student Guide 1 Title: Applications in Transfusion Medicine A CBL Exercise Purpose: At the conclusion of this exercise, students will be able to apply

More information

Prothrombin Complex Concentrate- Octaplex. Octaplex

Prothrombin Complex Concentrate- Octaplex. Octaplex Prothrombin Complex Concentrate- Concentrated Factors Prothrombin Complex Concentrate (PCC) 3- factor (factor II, IX, X) 4-factor (factors II, VII, IX, X) Activated 4-factor (factors II, VIIa, IX, X) Coagulation

More information

Transfusion Medicine Kris0ne Kra1s, M.D.

Transfusion Medicine Kris0ne Kra1s, M.D. Transfusion Medicine Kris0ne Kra1s, M.D. Transfusion Medicine Outline Blood groups Introduc0on ABO system Rh system Other systems Blood transfusion Blood products Indica0ons Tes0ng Dangers Transfusion

More information

When should I transfuse platelets and plasma for children? Dr Liz Chalmers. Consultant Paediatric Haematologist Royal Hospital for Children Glasgow

When should I transfuse platelets and plasma for children? Dr Liz Chalmers. Consultant Paediatric Haematologist Royal Hospital for Children Glasgow When should I transfuse platelets and plasma for children? Dr Liz Chalmers Consultant Paediatric Haematologist Royal Hospital for Children Glasgow When should I transfuse platelets and plasma in children?

More information

GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS

GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS GUIDELINES FOR MANAGEMENT OF BLEEDING AND EXCESSIVE ANTICOAGULATION WITH ORAL ANTICOAGULANTS This guideline covers the management of patients being treated with Vitamin K antagonists (VKA): Warfarin Acenocoumarol

More information

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University In The Name God Coagulation an Overview Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Research hcenter Shiraz Medical University Bleeding Clotting Hemostasis Review of platelet function Platelets

More information

STORMY DENGUE with bloody problems. Anand M.Patil PICU MED/SURG TEAM Apollo Childrens Hospitals Chennai

STORMY DENGUE with bloody problems. Anand M.Patil PICU MED/SURG TEAM Apollo Childrens Hospitals Chennai STORMY DENGUE with bloody problems Anand M.Patil PICU MED/SURG TEAM Apollo Childrens Hospitals Chennai 1 HISTORY 4 ½ years girl Day 1: Fever, Lethargy, Low urine output Hypotension, high PCV,low platelets

More information

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION

EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION EDUCATIONAL COMMENTARY DISSEMINATED INTRAVASCULAR COAGULATION Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE

More information

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance

Laboratory Empowerment. Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance Laboratory Empowerment Debbie Asher Adrian Ebbs Transfusion Laboratory Managers, Eastern Pathology Alliance Why? Electronic ICE requesting was in use for requesting red cells NBTC Indication Codes were

More information

Easy Bleeding General Presentation

Easy Bleeding General Presentation Easy Bleeding General Presentation It is not uncommon for children to bleed and bruise after experiencing trauma. However, a child may also have an underlying coagulopathy, which results in easy and possibly

More information

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD

Massive Transfusion. MPQC Spring Summit April 29, Roger Belizaire MD PhD Massive Transfusion MPQC Spring Summit April 29, 2015 Roger Belizaire MD PhD Take home points 1. Blood is always available. Requests for massive transfusion or emergency release typically only require

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

Heme (Bleeding and Coagulopathies) in the ICU

Heme (Bleeding and Coagulopathies) in the ICU Heme (Bleeding and Coagulopathies) in the ICU General Topics To Discuss Transfusions DIC Thrombocytopenia Liver and renal disease related bleeding Lack of evidence in managing critical illness related

More information

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore

MANAGEMENT OF COMMON BLEEDING DISORDERS. Auro Viswabandya Department of Haematology, CMC, Vellore MANAGEMENT OF COMMON BLEEDING DISORDERS Auro Viswabandya Department of Haematology, CMC, Vellore BLOOD CLOT : PRIMARY HAEMOSTASIS (Platelets) + SECONDARY HAEMOSTASIS (Coagulation Factors) HAEMOSTATIC DISORDERS

More information

Blood Transfusion. Dr William Dooley

Blood Transfusion. Dr William Dooley Blood Transfusion Dr William Dooley Plan Cases Blood groups / Indications Procedure Monitoring / Reactions Cases For following cases: - Would you give them a blood transfusion? - How many units you would

More information

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Things to never miss in the office Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC Presenter Disclosure Faculty / Speaker s name: Brett Houston / Leonard Minuk Relationships with commercial

More information

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital What do you do when the bleeding won t stop? Teddie Tanguay RN, MN, NP, CNCC(c) Teddie Tanguay RN, MN, NP, CNCC(c) Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital Outline Case study Normal coagulation

More information

Nicole Laferriere MD PhD FRCPC April 10, Patient Case Studies: Sticky Situations For Platelet Transfusions

Nicole Laferriere MD PhD FRCPC April 10, Patient Case Studies: Sticky Situations For Platelet Transfusions Nicole Laferriere MD PhD FRCPC April 10, 2019 Patient Case Studies: Sticky Situations For Platelet Transfusions Disclosures Ad Board: Celgene, Jansen, Takeda, Roche, Sanofi, Leo, Shire, Servier, Phizer,

More information

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference

Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference Use of Prothrombin Complex Concentrate to Reverse Coagulopathy Rio Grande Trauma Conference John A. Aucar, MD, MSHI, FACS, CPE EmCare Acute Care Surgery Del Sol Medical Center Associate Professor, University

More information

Blood/Blood Component Utilization and Administration Annual Compliance Education

Blood/Blood Component Utilization and Administration Annual Compliance Education Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:

More information

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components

Transfusion Pitfalls. Objectives. Packed Red Blood Cells. TRICC trial (subgroups): Is transfusion always good? Components Objectives Transfusion Pitfalls Gregory W. Hendey, MD, FACEP Professor and Chief UCSF Fresno, Emergency Medicine To list risks and benefits of various blood products To discuss controversy over liberal

More information

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?

Components of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give? Components of Blood Formed elements Cells Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets) Plasma 90% water 10% solutes Proteins, clotting factors 1 What can we give? Whole blood Packed RBC

More information

Major Haemorrhage Protocol. Commentary

Major Haemorrhage Protocol. Commentary Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey

More information

Unit 5: Blood Transfusion

Unit 5: Blood Transfusion Unit 5: Blood Transfusion Blood transfusion (BT) therapy: Involves transfusing whole blood or blood components (specific portion or fraction of blood lacking in patient). Learn the concepts behind blood

More information

Haemostasis & Coagulation disorders Objectives:

Haemostasis & Coagulation disorders Objectives: Haematology Lec. 1 د.ميسم مؤيد علوش Haemostasis & Coagulation disorders Objectives: - Define haemostasis and what are the major components involved in haemostasis? - How to assess the coagulation status?

More information

Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department

Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC) Dr. Klara Vezendi Szeged University Transfusiology Department Disseminated intravascular coagulation (DIC, consumptive coagulopathy) is a clinicopathologic

More information

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD Blood transfusion Dr. J. Potgieter Dept. of Haematology NHLS - TAD General Blood is collected from volunteer donors >90% is separated into individual components and plasma Donors should be: healthy, have

More information

Clinical & Laboratory Assessment

Clinical & Laboratory Assessment Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment

More information

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events WRHA Blood Conservation Service WRHA Transfusion Practice Committee TEAM TRANSFUSION Differential Diagnosis of Adverse Events MANITOBA ADVERSE EVENT REPORTING SYSTEM DATA FLOW REACTION Physician orders

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

EMSS17: Bleeding patients course material

EMSS17: Bleeding patients course material EMSS17: Bleeding patients course material Introduction During the bleeding patients workshop at the Emergency Medicine Summer School 2017 (EMSS17) you will learn how to assess and treat bleeding patients

More information

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D.

Bleeding and Thrombotic Disorders. Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Kristine Krafts, M.D. Bleeding and Thrombotic Disorders Bleeding disorders von Willebrand disease Hemophilia A and B DIC TTP/HUS ITP Thrombotic disorders Factor V Leiden

More information

Hemostatic Resuscitation

Hemostatic Resuscitation Hemostatic Resuscitation 30 th David Miller Trauma Symposium Bill Beck, MD Assistant Professor of Surgery Trauma, Emergency General Surgery, Critical Care Disclosures None Again. Mac user. Why I Like Trauma?

More information

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway

Hematology Review. CCRN exam. The Coagulation Cascade. The Coagulation Cascade. Components include: Intrinsic pathway Extrinsic pathway Common pathway CCRN exam Hematology Review CCRN Review October 2013 Department of Critical Care Nursing Hematology is 2% of the exam Focus on coagulation cascade, DIC, and HIT Anatomy of the hematologic system Bone marrow

More information

Easy bruising vs Coagulopathy

Easy bruising vs Coagulopathy Easy bruising vs Coagulopathy Sept. 19, 2015 Lakehead Summer School Chris Hillis, MD MSc FRCPC hillis@hhsc.ca @HemeHillis Aim & Objectives Aim: To increase comfort in detecting non-pathologic bleeding

More information

Clinical Guidance. Neonatal Manual Chapter 8: Haematology

Clinical Guidance. Neonatal Manual Chapter 8: Haematology Clinical Guidance Neonatal Manual Chapter 8: Haematology Summary This manual contains clinical guidelines developed by the Neonatal Unit multidisciplinary team over recent years. This chapter contains

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Transfusion Challenges - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016 Guidance on Transfusion Hospital transfusion guidelines and procedures Irish Blood Transfusion Service

More information

PCCN Review Hematology

PCCN Review Hematology PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency

More information

BMS Education Day 28 th January and 4th February 2013

BMS Education Day 28 th January and 4th February 2013 BMS Education Day 28 th January and 4th February 2013 Category of Reaction 24 hours from the transfusion = DELAYED Infectious Bacterial contamination Viral HIV,

More information

Major Haemorrhage Transfusion Pathway

Major Haemorrhage Transfusion Pathway Major Haemorrhage Transfusion Pathway SENIOR CLINICIAN ASSESSMENT: DECLARES MAJOR HAEMORRHAGE ( Call for help ( Telephone via switchboard: Consultant or Senior Clinician Duty Anaesthetist Porters (if will

More information

Fresh Frozen Plasma (FFP) and Cryoprecipitate Patient information

Fresh Frozen Plasma (FFP) and Cryoprecipitate Patient information Fresh Frozen Plasma (FFP) and Cryoprecipitate Patient information What are Fresh Frozen Plasma (FFP) and Cryoprecipitate? FFP and Cryoprecipitate (often just called cryo ) are both blood components made

More information

Appendix 3 PCC Warfarin Reversal

Appendix 3 PCC Warfarin Reversal Appendix 3 PCC Warfarin Reversal Reversal of Warfarin and Analogues 1. Principle of Procedure Guidelines for the Reversal of Oral-anticoagulation in the Event of Life Threatening Haemorrhage Prothrombin

More information

Princess Alexandra Hospital Emergency Department. Clinical Module. Clinical features of envenoming: Major toxin syndromes 1 :

Princess Alexandra Hospital Emergency Department. Clinical Module. Clinical features of envenoming: Major toxin syndromes 1 : Princess Alexandra Hospital Emergency Department Clinical Module Toxicology Review Officer: Toxicology registrar Version no: 1 Approval date: February 2017 Review date: February 2019 Approving Officer

More information

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient

Bleeding, Coagulopathy, and Thrombosis in the Injured Patient Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial

More information

CAUTION: Refer to the Document Library for the most recent version of this document. Cryoprecipitate Transfusion Guideline for Practice.

CAUTION: Refer to the Document Library for the most recent version of this document. Cryoprecipitate Transfusion Guideline for Practice. Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published

More information

Guidelines for the management of warfarin reversal in adults

Guidelines for the management of warfarin reversal in adults SharePoint Location Clinical Policies and Guidelines SharePoint Index Directory General Policies and Guidelines Sub Area Haematology and Transfusion Key words (for search purposes) Warfarin, Bleeding Central

More information

Pretransfusion Testing

Pretransfusion Testing Pretransfusion Testing Blood transfusion services The immunohematologic testing needed for By proper patient blood typing, component Dr. selection Reham and Talaat compatibility testing. Which Blood ensure

More information

Blood Transfusion. Dr Will Dooley

Blood Transfusion. Dr Will Dooley Blood Transfusion Dr Will Dooley Plan Cases OSCE practice scenario Blood groups Monitoring / Reactions Miss Irene Bleede, 23yo Asymptomatic, healthy woman with menorrhagia Hb 78 g/l, MCV 73fl Would you

More information

There are two main causes of a low platelet count

There are two main causes of a low platelet count Thrombocytopenia Thrombocytopenia is a condition in which a person's blood has an unusually low level of platelets Platelets, also called thrombocytes, are found in a person's blood along with red blood

More information

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY

MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):

More information

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 What type of tissue is blood? Blood is considered liquid connective

More information

FELINE HEMATOLOGY Inherited and Acquired Bleeding Disorders Marjory Brooks DVM, D.ACVIM

FELINE HEMATOLOGY Inherited and Acquired Bleeding Disorders Marjory Brooks DVM, D.ACVIM FELINE HEMATOLOGY Marjorie Brooks, D.V.M. Diplomate, A.C.V.I.M. Comparative Hematology Laboratory N.Y.S. Department of Health WCL&R P. O. Box 509 Albany, NY 12201 f / b - f / i 3 FELINE HEMATOLOGY Inherited

More information

ADMINISTRATIVE CLINICAL Page 1 of 6

ADMINISTRATIVE CLINICAL Page 1 of 6 ADMINISTRATIVE CLINICAL Page 1 of 6 Anticoagulant Guidelines #2: REVERSAL OF OR MANAGEMENT OF BLEEDING WITH ANTICOAGULANTS Origination Date: Revision Date: Reviewed Date: 09/12 09/12, 01/13, 11/13, 11/15

More information

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban

Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Guidance for management of bleeding in patients taking the new oral anticoagulant drugs: rivaroxaban, dabigatran or apixaban Purpose The aim of this guidance is to outline the management of patients presenting

More information

Specific Requirements

Specific Requirements Specific Requirements AIMS Specific requirements your patients have for transfusion and how this is managed Classify which patients require: Irradiated components CMV negative components Washed components

More information

COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS

COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS COAGULATION PROFILE AND ANALYSIS OF OUTCOME OF BLOOD COMPONENT THERAPY IN SNAKE BITE VICTIMS Dr Aboobacker Mohamed Rafi 1, Dr Susheela J Innah Senior Resident Department of Transfusion Medicine Jubilee

More information

Hemostatic derangement in Dengue infection

Hemostatic derangement in Dengue infection Hemostatic derangement in Dengue infection By Assoc. Prof. Darintr Sosothikul, MD Pediatric Hematology-Oncology division, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University

More information

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary

Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Dr Shikha Chattree Haematology Consultant Sunderland Royal infirmary Increasing use of Novel Oral Anticoagulants (NOACs) in the management of prophylaxis and management of venous thromboembolism and in

More information

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014 What You Need to Know About Blood Transfusion Elianna Saidenberg May 2014 Objectives Why your doctor might order transfusion therapy Where does the blood come from The beginning of your transfusion Consent

More information

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD

MS.4/ Acute Leukemia: AML. Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD MS.4/ 27.02.2019 Acute Leukemia: AML Abdallah Al Abbadi.MD.FRCP.FRCPath Feras Fararjeh MD Case 9: Acute Leukemia 29 yr old lady complains of fever and painful gums for 1 week. She developed easy bruising

More information

Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18

Blood Product Utilization A Mythbusters! Style Review. Amanda Haynes, DO 4/28/18 Blood Product Utilization A Mythbusters! Style Review Amanda Haynes, DO 4/28/18 Objectives Describe concepts in Patient Blood Management Review common misconceptions surrounding blood transfusion Summarize

More information

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne

My Bloody Talk. Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne My Bloody Talk Dr Ben Turner MBBS, FANZCA, FCICM The Royal Children s Hospital, Melbourne Disclosures No conflicts of interest Interest in conflict Blood transfusion Massive transfusion definitions Transfusion

More information

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY Lexington, KY Page 1 of 13 Affected Sites: Enterprise Chandler X Good Samaritan I. PRINCIPLE: The UK Good Samaritan Hospital is dedicated to serve the patients with safe, high quality blood products and

More information

Bleeding Disorders HOPE Maram Al-anbar

Bleeding Disorders HOPE Maram Al-anbar Bleeding Disorders HOPE Maram Al-anbar 9-9 - 2014 ^^ Attention Please ^^ We ( correction team of pediatric package^hope/2010^ ) had decided to make one lecture of bleeding disorders in place of the two

More information

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College

Haemorrhagic Disorders. Dr. Bashar Department of Pathology Mosul Medical College Haemorrhagic Disorders Dr. Bashar Department of Pathology Mosul Medical College Hemorrhagic Disorders These include Disorders of platelets. Disorders of blood vessels. Disorders of coagulation & fibrinolysis.

More information

BLOOD TRANSFUSION. Dr Lumka Ntabeni

BLOOD TRANSFUSION. Dr Lumka Ntabeni BLOOD TRANSFUSION Dr Lumka Ntabeni Blood transfusion definition SAFE transfer of BLOOD COMPONENTS from a DONOR to a RECEPIENT CONTENT Brief history of blood transfusion How is safety guaranteed? How do

More information

23/10/2011. Case One: Mrs. B. Mrs. B., 36 year old, 30 weeks pregnant, 2 nd baby Blood type A negative Belted driver of minivan, struck a parked car

23/10/2011. Case One: Mrs. B. Mrs. B., 36 year old, 30 weeks pregnant, 2 nd baby Blood type A negative Belted driver of minivan, struck a parked car GETTING IT BLOODY RIGHT: CHOOSING THE BEST PRODUCT Kathleen Eckert, ART, Transfusion Safety Officer, LHSC Brenda Morgan, RN BScN MSc, CNS, Critical Care, Victoria Hospital, LHSC http://www.transfusionontario.org/public-en/public.php

More information

Conflicts. Objectives. University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 24 August Pediatric Dermatology 101

Conflicts. Objectives. University of Texas Health Science Center at San Antonio. Pediatrics Grand Rounds 24 August Pediatric Dermatology 101 Pediatric Dermatology 101 John C. Browning, MD, FAAD, FAAP Conflicts Investigator: ViroXis Advisor: ViroXis Advisory Board: TopMD Speaker: Galderma Objectives Understand the meaning and importance of cutaneous

More information